Scholars Central

Conference abstract

Development of HPLC-UV/MS-MS methods applied to the quality control of Ursodeoxycholic acid in oral liquid pediatric formulations and raw material

Authors: Boscolo O, Flor S, Martinefski M, Buontempo F, Tripodi V, Lucangioli S

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Ursodeoxycholic acid (UDCA), is a bile acid used to dissolve gallstones and for the treatment of hepatobiliary diseases. It is the only drug approved by the FDA for the treatment of primary biliary cirrhosis. In UDCA, raw material or other bile acids may be present as impurities. Some of them, like lithocholic acid (LCA) are highly toxic and others are associated with several side effects such as chenodeoxycholic acid (CDCA). USP (United States Pharmacopeia) describes the determination of CDCA and LCA by TLC, where each impurity limit should be not more than 1.5% and 0.02% respectively. The aim of this work was to develop and validated an analytical method by HPLC-UV for the determination of UDCA in oral liquid pharmaceutical formulations for pediatrics administration. Also, the impurities present in the raw material were determined by HPLC / MS-MS. HPLC-UV system was applied to a C18 Symmetry column (150 mm x 4.6 mm ID, particle size 3.5 μm, Water), mobile phase ACN:H2O pH 3 (48:52), column temperature 40° C, flow rate 1 mL/min, injection volume 100 μL and detection UV 200 nm. In the determination of impurities the chromatography method was carried isocratically at 25°C, using a column C18 Symmetry, mobile phase methanol:acetonitrile:10mM ammonium acetate buffer (40:40:20) and flow rate 0.4 mL/min. Negative polarity and SRM mode were set for MS detection. The parameters optimized were: Voltage, sheath gas pressure and turbulence offset. Both methods were validated in terms of specificity, LOD (Limit of Detection), LOQ (Limit of Quantification), linearity, precision, accuracy and robustness. The developed methods meet specifications and are suitable for quality control.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmacovigilance
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Boscolo O”
  • BylineArticles whose byline prints “Flor S”
  • BylineArticles whose byline prints “Martinefski M”
  • BylineArticles whose byline prints “Buontempo F”
  • BylineArticles whose byline prints “Tripodi V”
  • BylineArticles whose byline prints “Lucangioli S”